Year: 2010
Type: editorial
Abstract: Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma.
Source: Journal of Clinical Oncology
Authors: Daniel J. Sargent, Stephen L. George
Institutions: Mayo Clinic, Duke University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
OpenAlex ID: W2171885520